Variant report
Variant | nsv511529 |
---|---|
Chromosome Location | chr14:20553680-20562080 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr14:20561670-20561913 | K562 | blood: | n/a | n/a |
2 | CTCF | chr14:20556922-20556953 | LNCaP | prostate: | n/a | n/a |
3 | CTCF | chr14:20556740-20556890 | AG04449 | skin: | n/a | n/a |
4 | CTCF | chr14:20556820-20556970 | HEK293 | kidney: | n/a | chr14:20556904-20556922 |
5 | CTCF | chr14:20556840-20556990 | MCF-7 | breast: | n/a | chr14:20556904-20556922 |
6 | E2F4 | chr14:20558815-20559015 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | JUN | chr14:20560254-20560445 | K562 | blood: | n/a | n/a |
8 | POLR2A | chr14:20561432-20561947 | HL-60 | blood: | n/a | n/a |
9 | RCOR1 | chr14:20561585-20561948 | K562 | blood: | n/a | n/a |
10 | SPI1 | chr14:20561623-20561896 | K562 | blood: | n/a | chr14:20561775-20561784 chr14:20561679-20561692 chr14:20561773-20561786 |
11 | SPI1 | chr14:20561499-20562022 | HL-60 | blood: | n/a | chr14:20561775-20561784 chr14:20561679-20561692 chr14:20561773-20561786 |
12 | SPI1 | chr14:20561551-20561924 | HL-60 | blood: | n/a | chr14:20561775-20561784 chr14:20561679-20561692 chr14:20561773-20561786 |
13 | TEAD4 | chr14:20561489-20561950 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNA5SP380 | TF binding region |
OR4T1P | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150970436 | chr14:20556759-20556760 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs552879226 | chr14:20556772-20556773 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs566688182 | chr14:20556792-20556793 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs188558142 | chr14:20556823-20556824 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs181603478 | chr14:20556896-20556897 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs570652355 | chr14:20556903-20556904 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs538090256 | chr14:20556910-20556911 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs556204500 | chr14:20556979-20556980 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs535792108 | chr14:20558839-20558840 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs554423832 | chr14:20558859-20558860 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs572382360 | chr14:20558862-20558863 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs539810914 | chr14:20558875-20558876 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs12590521 | chr14:20558876-20558877 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs12588910 | chr14:20558938-20558939 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs199781272 | chr14:20558946-20558947 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs77480255 | chr14:20558983-20558984 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs74585844 | chr14:20560258-20560259 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs75010817 | chr14:20560259-20560260 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs116033362 | chr14:20560281-20560282 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs183806811 | chr14:20560299-20560300 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs537435525 | chr14:20560314-20560315 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs12890274 | chr14:20560354-20560355 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs567754143 | chr14:20560371-20560372 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs188912447 | chr14:20560398-20560399 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs192402696 | chr14:20560432-20560433 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs534730186 | chr14:20560434-20560435 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs373828660 | chr14:20560439-20560440 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs556882805 | chr14:20561437-20561438 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs57793822 | chr14:20561481-20561482 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs572728791 | chr14:20561631-20561632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540357070 | chr14:20561656-20561657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184704879 | chr14:20561712-20561713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563668196 | chr14:20561733-20561734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs4144240 | chr14:20561753-20561754 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs148639678 | chr14:20561764-20561765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116638051 | chr14:20561783-20561784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs111649968 | chr14:20561802-20561803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs201569304 | chr14:20561820-20561821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573562609 | chr14:20561822-20561823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9323500 | chr14:20561847-20561848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562264558 | chr14:20561858-20561859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs78707650 | chr14:20561910-20561911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4144239 | chr14:20561922-20561923 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs571404215 | chr14:20561942-20561943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547940017 | chr14:20561949-20561950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs74037232 | chr14:20561953-20561954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550370303 | chr14:20561969-20561970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs4144238 | chr14:20561971-20561972 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cone-rod dystrophy | 18421352 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Alzheimer''s disease | 21482944 | CNVD |
Mental retardation | 19951919 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 16773561 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17440070 | CNVD |
Breast cancer | 16272173 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
severe speech impairment | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Breast cancer | 21509527 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:20561600-20562000 | Enhancers | Primary neutrophils fromperipheralblood | blood |